Sars-cov-2 t-cell responses in allogeneic hematopoietic stem cell recipients following two doses of bnt162b2 mrna vaccine

HIGHLIGHTS

• who: Bu00e9atrice Clu00e9menceau and colleagues from the Hematology Department, University Hospital, University, France have published the research work: SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine, in the Journal: Vaccines 2022, 10, 448. of /2022/
• what: After two doses of BNT162b2 vaccine, a strong IFN-u03b3- /TNF-u03b1+ response by SARS-CoV-2-specific CD4+ T-cells can be detected in a majority of humoral HR (89%) and many NHR (40%) Allo-HSCT recipients.

SUMMARY

Since its appearance in the . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.